Optimer Pharmaceuticals (OPTR)

14.97 -0.14  -0.93%  May 17, 8:00PM
Add to Watchlists Create an Alert

Optimer Pharmaceuticals Cash from Investing Quarterly:

65.82M for Dec. 31, 2012
View Full Chart

Optimer Pharmaceuticals Cash from Investing Quarterly Chart

    Optimer Pharmaceuticals Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 65.82M
    Sept. 30, 2012 18.90M
    June 30, 2012 17.08M
    March 31, 2012 17.49M
    Dec. 31, 2011 2.841M
    Sept. 30, 2011 14.02M
    June 30, 2011 -57.28M
    March 31, 2011 -11.14M
    Dec. 31, 2010 2.037M
    Sept. 30, 2010 3.549M
    June 30, 2010 -2.303M
    March 31, 2010 -12.03M
    Dec. 31, 2009 2.089M
       
    Sept. 30, 2009 1.560M
    June 30, 2009 -9.062M
    March 31, 2009 6.782M
    Dec. 31, 2008 0.0818M
    Sept. 30, 2008 3.401M
    June 30, 2008 4.809M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Sept. 30, 2006 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    OPTR Cash from Investing Quarterly Benchmarks

    Companies
    Cubist Pharmaceuticals -29.37M
    AstraZeneca -364.00M
    Theravance -45.01M

    OPTR Cash from Investing Quarterly Rankings

    Overall 98th percentile
    151 of 7590
    Sector 98th percentile
    9 of 651 in Healthcare
    Industry 98th percentile
    4 of 238 in Biotechnology

    OPTR Cash from Investing Quarterly Range, Past 5 Years

    Minimum -57.28M Jun 2011
    Maximum 65.82M Dec 2012
    Average 3.613M